Home > Healthcare > Medical Devices > Rehabilitation and Assistive Devices > Diabetic Footwear Market

Diabetic Footwear Market Size

  • Report ID: GMI6062
  • Published Date: Jun 2023
  • Report Format: PDF

Diabetic Footwear Market Size

Diabetic Footwear Market was valued at around 7.2 billion in 2023 and is anticipated to grow at a CAGR of 6.5% between 2024 and 2032. This market revenue is attributable to the several factors comprising the development of advanced materials and manufacturing techniques that has improved the quality and functionality of diabetic footwear. Companies are incorporating features such as cushioning, moisture-wicking properties, seamless interiors, and adjustable closures to enhance comfort & reduce the risk of foot complications. Diabetic footwear manufacturers are increasingly focusing on customization and personalization to cater to individual foot conditions. This includes offering various width and depth options, as well as accommodating orthotic inserts and modifications to meet specific patient needs.

 

Similarly, companies in the diabetic footwear market are collaborating with podiatrists and other healthcare professionals to gain insights into patient needs and to ensure that their products meet medical standards. Such collaborations help in developing effective footwear solutions and establishing credibility within the healthcare community. As a result, technological advancements, customization & personalization, and collaboration with healthcare professionals is augmenting the market revenue.

 

Diabetic footwear refers to specially designed shoes and footwear accessories that are created to provide optimal comfort, support, and protection for individuals with diabetes. People with diabetes are prone to foot-related complications, such as poor circulation, nerve damage, and foot ulcers, that can lead to serious health issues. Diabetic footwear aims to reduce these risks by incorporating features that promote foot health and minimize the occurrence of foot problems.

 

However, high cost associated with diabetic footwear may obstruct the segment revenue. The price range for diabetic footwear can vary depending on various factors such as the brand, quality, style, and additional features. On average, diabetic footwear typically ranges from USD 50 to USD 200 or more. On average, diabetic shoes can range from around USD 80 to USD 200 or more per pair. Similarly, some specialty diabetic footwear, such as custom-made shoes or those with advanced features, may cost more. These costs highlight that diabetic footwear can be more expensive compared to regular shoes. This is attributable to the regulatory compliance, specialized designs, and customization among others. Thus, high cost associated with diabetic footwear may hinder the business growth.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Marker size for diabetic footwear was worth USD 7.2 billion in 2023 and is set to reach over USD 11.9 billion by 2032, driven by the surging need for improved quality and functionality of diabetic through advanced manufacturing techniques.

Diabetic footwear industry share from the shoe product segment exceeded USD 2.3 billion in 2022 propelled by the growing diabetic population, increasing awareness, and the advent of innovative features.

U.S. diabetic footwear valuation is estimated to reach USD 4.6 billion by 2032 attributed to the increasing prevalence of diabetes and the growing awareness about the importance of foot care among diabetic individuals.

Some of the major diabetic footwear players include Aetrex Worldwide, Apex Foot Health Industries, LLC, DJO Global Inc., Dr. Comfort, Dr. Zen Products Inc., Drew Shoe Corporation, Finn Comfort among others.

Diabetic Footwear Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 454
  • Countries covered: 30
  • Pages: 180
 Download Free Sample